Marks & Clerk is well placed to advise pharmaceutical and medtech companies — ranging from start-ups to global leaders — and universities in patent litigation and prosecutions at the national and international level. The practice, which also advises on trade mark, designs, copyright and brand protection, is led by patent litigator Mike Gilbert, and Will Nieuwenhuys, who handles the full range of patent matters. Graham Burnett-Hall is no longer at the firm.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Well rounded team, well able to handle technically and legally complex cases, great knowledge of the pharma industry, great team work, works well with firms in other jurisdictions, transparent, open to dialogue, always responsive.'
- 'Mike Gilbert is very experienced and respected, capable of handling legally and technically complex cases, he is pragmatic and sees the whole picture when providing legal advice, has a really good knowledge of the pharma/life sciences industry, and stays calm under pressure. He is client oriented, and transparent and open to discussion about case management, resource allocation etc. He works very well with others in multi-country litigation situations. A great team leader.'
Key clients
- Pfizer
- Daiichi Sankyo
- Gilead Sciences
- Roche
- Advanced Medical Solutions
- Meril Life Sciences
- RevoluGen
- Inside Biometrics Limited
- Sumitomo Pharma America, Inc.
- Menarini
- Oxford Cannabinoid Technologies
Work highlights
Represented Pfizer in a complex three-patent revocation action against GSK relating to 3 of GSK’s patents concerning features of RSV vaccines.
Instructed by Meril Life Sciences to assist incumbent firms with ongoing litigation before the UPC and in the UK.
Advising Gilead on European patent portfolios.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Mike Gilbert; Will Nieuwenhuys
Other key lawyers
Charlie Balme; Will Arends; Dan McGrath; Marcus Riby-Smith; Mari Brace